BMP signaling mediated by ALK2 in the visceral endoderm is necessary for the generation of primordial germ cells in the mouse embryo

  1. Susana M. Chuva de Sousa Lopes1,
  2. Bernard A.J. Roelen2,3,5,6,
  3. Rui M. Monteiro1,
  4. Roul Emmens1,
  5. Herbert Y. Lin2,3,5,
  6. En Li4,5,7,
  7. Kirstie A. Lawson1, and
  8. Christine L. Mummery1,8
  1. 1Hubrecht Laboratory, Netherlands Institute for Developmental Biology, Uppsalalaan 8, 3584 CT Utrecht, The Netherlands; 2Program in Membrane Biology, 3Renal Unit, and 4Cardiovascular Research Center, Massachusetts General Hospital, Charlestown, Massachusetts 02129, USA; 5Department of Medicine, Harvard Medical School, Charlestown, Massachusetts 02129, USA

Abstract

Deletion of various bone morphogenetic proteins (BMPs) and their downstream Smads in mice have clearly shown that BMP signaling is essential for the formation of primordial germ cells (PGCs). However, the molecular mechanism through which this takes place is still unclear. Here, we demonstrate that BMP4 produced in the extraembryonic ectoderm signals through ALK2, a type I BMP receptor, in the visceral endoderm (VE) to induce formation of PGCs from the epiblast. Firstly, embryonic day 5.5–6.0 (E5.5–E6.0) embryos cultured on fibronectin formed PGCs in the presence of VE, but not in its absence. Secondly, Alk2-deficient embryos completely lacked PGCs and the heterozygotes had reduced numbers, resembling Bmp4-deficient phenotypes. Thirdly, expression of constitutively active ALK2 in the VE, but not in the epiblast, was sufficient to rescue the PGC phenotype in Bmp4-deficient embryos. In addition, we show that the requirement for the VE at E5.5–E6.0 can be replaced by culturing embryos stripped of VE on STO cells, indicating that STO cells provide or transduce signals necessary for PGC formation that are normally transmitted by the VE. We propose a model in which direct signaling to proximal epiblast is supplemented by an obligatory indirect BMP-dependent signal via the VE.

Keywords

Footnotes

  • Article and publication are at http://www.genesdev.org/cgi/doi/10.1101/gad.294004.

  • 6 Present address: Department of Farm Animal Health, Faculty of Veterinary Medicine, Utrecht University, 3584CL Utrecht, The Netherlands

  • 7 Present address: Models of Disease Center, Novartis Institute for Biomedical Research, 100 Technology Square, Cambridge, MA 02139, USA

  • 8 Corresponding author. E-MAIL christin{at}niob.knaw.nl; FAX 31-30-2516464.

    • Accepted May 21, 2004.
    • Received December 5, 2003.
« Previous | Next Article »Table of Contents